DermaCare developed a new product for the treatment of acne, what they hope to sell to consumers through direct response television. Unconventional nature of the product and its distribution led the company to seek angel financing. The Band Silicon Valley Angels agreed to fund the company and presented the proposed term sheet. Recently, however, venture capital (VC) group presented a competing term sheet. The company must decide whether to accept funding from a group of angels or VC. "Hide
by Richard G. Hamermesh, Lauren Barley Source: HBS Premier Case Collection 21 pages. Publication Date: September 21, 2007. Prod. #: 808064-PDF-ENG
Related Case Solutions & Analyses:
Shanghai General Motors: The Rise of a Late-Comer
International Securities Exchange: New Ground in Options Markets
Cell Network (C): From Take-Off to Mainstream
Tonernow.com: Dotcom Goes Global
Note on New Drug Development in the United States
Agricultural Material Sourcing within the Concept of Creating Shared Value (CSV)
Carolina Heart care
Rambus Imaging Systems
H. J. Heinz Estimating the Cost of Capital in Uncertain Times
ENIGMA ESCAPE ROOMS
